# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...
HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(...
-SEC Filing
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate ...